EN | DE
 info(at)helmholtz-hips.de +49681988063001
 Directions to Google
EN | DE
Researchers in HIPS Laboratory

Search

Searched for "drug". Displaying results 151 to 160 of 748.

Drug solubility in biorelevant media in the context of an inhalation-based biopharmaceutics classification system (iBCS)

Publication
Floroiu A, Loretz B, Krämer J, Lehr C (2024)
Eur J Pharm Biopharm, 197, 10.1016/j.ejpb.2024.114206, 38316234

Drug transport across pulmonary epithelial cell monolayers: effects of particle size, apical liquid volume, and deposition technique

Publication
Bur M, Huwer H, Muys L, Lehr C (2010)
Journal of aerosol medicine and pulmonary drug delivery, 23, 3, 119-27, 10.1089/jamp.2009.0757, 20073555

Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties

Publication
Huck B, Murgia X, Frisch S, Hittinger M, Hidalgo A, Loretz B, Lehr C (2022)
Advanced Drug Delivery Reviews, 183, 10.1016/j.addr.2022.114141, 35149123

A Custom-Made Device for Reproducibly Depositing Pre-metered Doses of Nebulized Drugs on Pulmonary Cells in vitro

Publication
Horstmann J, Thorn C, Carius P, Graef F, Murgia X, Souza Carvalho-Wodarz C, Lehr C (2021)
Frontiers in Bioengineering and Biotechnology, 9, 10.3389/fbioe.2021.643491, 33968912

Facile Production of the Pseudomonas aeruginosa Virulence Factor LasB in E. coli for Structure-Based Drug Design

Publication
Kolling D, Haupenthal J, Hirsch A, Köhnke J (2023)
ChemBioChem, 10.1002/cbic.202300185, 37195753

Carrier interactions with the biological barriers of the lung: Advanced in vitro models and challenges for pulmonary drug delivery

Publication
de Souza Carvalho C, Daum N, Lehr C (2014)
Advanced Drug Delivery Reviews, 75, 129-140, 10.1016/j.addr.2014.05.014, 24880145

Drug delivery to the inflamed intestinal mucosa- targeting technologies and human cell culture models for better therapies of IBD

Publication
Olga H, Shetab Boushehri Maryam A, Shalaby Karim S, Brigitta L, Alf L, Claus-Michael L (2021)
Advanced Drug Delivery Reviews, 10.1016/j.addr.2021.113828, 34157320

A Monoclonal Human Alveolar Epithelial Cell Line ("Arlo") with Pronounced Barrier Function for Studying Drug Permeability and Viral Infections

Publication
Carius P, Jungmann A, Bechtel M, Grißmer A, Boese A, Gasparoni G, Salhab A, Seipelt R, Urbschat K, Richter C, Meier C, Bojkova D, Cinatl J, Walter J, Schneider-Daum N, Lehr C (2023)
Adv. Sci., 10, 8, 10.1002/advs.202207301, 36748276

Second Generation Tiancimycin-Based Antibody–Drug Conjugates Enabled by Highly Efficient Semi-synthetic Approach Specifically Targeting B-Cell Malignancies

Publication
Kiefer A, Thirugnanasambantham P, Jin Y, Steele A, Hwang D, Jiang Y, Adhikari A, Yang D, Chang J, Tafesse R, Rader C, Muthusamy N, Shen B (2025)
JACS Au, 10.1021/jacsau.5c00353

Nano- and microscaled particles for drug targeting to inflamed intestinal mucosa - A first in vivo study in human patients

Publication
Schmidt C, Lautenschlaeger C, Collnot E, Schumann M, Bojarski C, Schulzke J, Lehr C, Stallmach A (2013)
Journal of Controlled Release, 165, 2, 139-145, 10.1016/j.jconrel.2012.10.019, 23127508